Quality of life assessment following peptide receptor radionuclide therapy (PRRT) of pancreatic neuroendocrine tumor (P-NET)

被引：0
|
作者：
Marinova, Milka [3 ]
Muecke, Martin [1 ]
Mahlberg, Lukas [2 ]
Essler, Markus [2 ]
Cuhls, Henning [1 ]
Radbruch, Lukas [1 ]
Ahmadzadehfar, Hojjat [2 ]
机构：
[1] Univ Hosp Bonn, Bonn, Germany
[2] Univ Hosp Bonn, Nucl Med, Bonn, Germany
[3] Univ Hosp Bonn, Radiol, Bonn, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1462
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Peptide receptor radionuclide therapy (PRRT) of midgut neuroendocrine tumors: assessment of quality of life
    Marinova, Milka
    Muecke, Martin
    Fischer, Felix
    Essler, Markus
    Cuhls, Henning
    Radbruch, Lukas
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [2] Morphology of Pancreatic Neuroendocrine Tumor (P-NET)
    Katsuta, E.
    Kudo, A.
    Ohata, Y.
    Ueda, H.
    Sato, T.
    Oba, A.
    Akahoshi, K.
    Nakao, K.
    Furuyama, T.
    Ito, H.
    Matsumura, S.
    Aihara, A.
    Ban, D.
    Ochiai, T.
    Irie, T.
    Tanaka, S.
    Tanabe, M.
    PANCREAS, 2014, 43 (08) : 1375 - 1375
  • [3] FDG PET as a Prognostic Factor in Pancreatic Neuroendocrine Tumors (P-NET) after Peptide Receptor Radionuclide Therapy with 177Lu-Dotatate (Lu-PRRT)
    Sansovini, M.
    Stefano, S.
    Ianniello, A.
    Nicolini, S.
    Fantini, L.
    Bongiovanni, A.
    Di Iorio, V
    Sarnelli, A.
    Monti, M.
    Paganelli, G.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 138 - 138
  • [4] Evaluation of toxicity in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S471 - S472
  • [5] Evaluation of Toxicity in Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumors (NET)
    Duan, H.
    Girod, B.
    Ninatti, G.
    Ferri, V
    Kunz, P.
    Fisher, G.
    Moradi, F.
    Davidzon, G.
    Franc, B.
    Lagaru, A.
    Aparici, Mari C.
    NEUROENDOCRINOLOGY, 2020, 110 : 252 - 252
  • [6] Single Institution Experience with Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ninatti, G.
    Girod, B.
    Ferri, V
    Guja, K.
    Song, H.
    Kunz, P.
    Fisher, G.
    Lagaru, A.
    Mari, Aparici C.
    NEUROENDOCRINOLOGY, 2020, 110 : 253 - 253
  • [7] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Kunz, Pamela L.
    Fisher, George A.
    Moradi, Farshad
    Davidzon, Guido Alejandro
    Franc, Benjamin Lewis
    Iagaru, Andrei
    Mari, Carina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P.
    Davidzon, G.
    Nguyen, J.
    Moradi, F.
    Franc, B.
    Iagaru, A.
    Aparici, C. Mari
    PANCREAS, 2021, 50 (03) : 456 - 456
  • [9] Assessment of somatostatin receptor expression in predicting results of PRRT (peptide receptor radionuclide therapy) in disseminated neuroendocrine tumours (NET)
    Hubalewska-Dydejayk, Alicja B.
    Sowa-Staszczak, Anna
    Trofimiuk, Malgorzata
    Stefanska, Agnieszka
    Wierzchowski, Wojciech
    Kunikowska, Jolanta
    Pach, Dorota
    Tomaszewska, Romana
    ENDOCRINE JOURNAL, 2010, 57 : S443 - S443
  • [10] Assessment of Somatostatin Receptors Expression in Predicting Results of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumours (NET)
    Sowa-Staszczak, A.
    Trofimiuk, M.
    Stefanska, A.
    Wierzchowski, W.
    Kunikowska, J.
    Mikolajczak, R.
    Pawlak, D.
    Pach, D.
    Tomaszewska, R.
    Krolicki, L.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S418 - S418
12345